Geode Capital Management
CRBU icon

Geode Capital Management’s Caribou Biosciences CRBU Stock Holding History

Geode Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93M Buy
1,017,959
+41,146
+4% +$70.6K ﹤0.01% 3135
2025
Q4 		$1.55M Sell
976,813
-8,313
-0.8% -$17.4K ﹤0.01% 3242
2025
Q3 		$2.3M Buy
985,126
+4,197
+0.4% +$7.92K ﹤0.01% 3128
2025
Q2 		$1.24M Sell
980,929
-1,073,000
-52% -$1.06M ﹤0.01% 3267
2025
Q1 		$1.88M Buy
2,053,929
+81,534
+4% +$106K ﹤0.01% 3060
2024
Q4 		$3.14M Sell
1,972,395
-58,048
-3% -$117K ﹤0.01% 2966
2024
Q3 		$3.98M Buy
2,030,443
+124,782
+7% +$256K ﹤0.01% 2884
2024
Q2 		$3.13M Buy
1,905,661
+63,478
+3% +$203K ﹤0.01% 2965
2024
Q1 		$9.47M Buy
1,842,183
+47,535
+3% +$293K ﹤0.01% 2359
2023
Q4 		$10.3M Buy
1,794,648
+217,507
+14% +$1.08M ﹤0.01% 2329
2023
Q3 		$7.54M Buy
1,577,141
+465,590
+42% +$2.89M ﹤0.01% 2422
2023
Q2 		$4.72M Buy
1,111,551
+41,927
+4% +$188K ﹤0.01% 2715
2023
Q1 		$5.68M Buy
1,069,624
+38,637
+4% +$241K ﹤0.01% 2579
2022
Q4 		$6.47M Buy
1,030,987
+45,617
+5% +$406K ﹤0.01% 2513
2022
Q3 		$10.4M Buy
985,370
+310,597
+46% +$2.89M ﹤0.01% 2221
2022
Q2 		$3.66M Buy
674,773
+26,016
+4% +$199K ﹤0.01% 2866
2022
Q1 		$5.96M Buy
648,757
+287,125
+79% +$3.03M ﹤0.01% 2701
2021
Q4 		$5.46M Buy
361,632
+19,417
+6% +$378K ﹤0.01% 2851
2021
Q3 		$8.17M Buy
+342,215
New +$8.37M ﹤0.01% 2611

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management's CRBU Position: Q1 2026 in Review

Geode Capital Management increased its Caribou Biosciences (CRBU) stake by 4.2% in Q1 2026, buying an estimated $70.6K and bringing the position to 1,017,959 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3135.

Geode Capital Management first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $10.4M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Geode Capital Management held 1,017,959 shares of Caribou Biosciences worth $1.93M as of Q1 2026.
  • Geode Capital Management bought 41,146 Caribou Biosciences shares in Q1 2026, an estimated $70.6K.
  • Caribou Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3135 holding.
  • Geode Capital Management first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Geode Capital Management's Caribou Biosciences position peaked at $10.4M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.